Literature DB >> 19141384

Immunostaining of plasma cells in primary biliary cirrhosis.

Jason A Daniels1, Michael Torbenson, Robert A Anders, John K Boitnott.   

Abstract

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease characterized by inflammatory destruction of the intrahepatic bile ducts. The differential diagnosis for PBC often includes autoimmune hepatitis (AIH). Both diseases can show prominent plasma cells and other overlapping histologic features. It is interesting that both diseases can involve elevated levels of serum immunoglobulins, with IgM elevations typical of PBC and IgG elevations typical of AIH. We investigated whether this difference could be useful histologically by immunostaining plasma cells in liver biopsy specimens for IgG and IgM. We examined 56 cases: 18 of PBC and 38 of AIH. In PBC, plasma cells in the portal tracts were predominantly IgM+, whereas in AIH, plasma cells were predominately IgG+ (P < .0001). Immunostaining for IgM and IgG can be helpful in differentiating PBC from AIH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141384     DOI: 10.1309/AJCP8WHR0IEVUUOJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis.

Authors:  Ourania Sfakianaki; Maria Tzardi; Argyro Voumvouraki; Aikaterini Afgoustaki; Meri Koulentaki; Elias Kouroumalis
Journal:  World J Hepatol       Date:  2013-10-27

Review 2.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Impact of microbes on autoimmune diseases.

Authors:  Claudia Danzer; Jochen Mattner
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-16       Impact factor: 4.291

4.  Tubulointerstitial Nephritis with IgM-Positive Plasma Cells.

Authors:  Naoki Takahashi; Takako Saeki; Atsushi Komatsuda; Chishio Munemura; Takeaki Fukui; Naofumi Imai; Noriyuki Homma; Tsuguru Hatta; Ken-Ichi Samejima; Takashi Fujimoto; Hiroki Omori; Yumi Ito; Yudai Nishikawa; Mamiko Kobayashi; Yukie Morikawa; Sachiko Fukushima; Seiji Yokoi; Daisuke Mikami; Kenji Kasuno; Hideki Kimura; Tomoyuki Nemoto; Yasunari Nakamoto; Kiyonao Sada; Manabu Sugai; Hironobu Naiki; Haruyoshi Yoshida; Ichiei Narita; Yoshihiko Saito; Masayuki Iwano
Journal:  J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 10.121

Review 5.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

6.  The utility of IgG, IgM, and CD138 immunohistochemistry in the evaluation of autoimmune liver diseases.

Authors:  Kazumichi Abe; Atsushi Takahashi; Yoshihiro Nozawa; Hiromichi Imaizumi; Manabu Hayashi; Ken Okai; Yukiko Kanno; Hiroshi Watanabe; Hiromasa Ohira
Journal:  Med Mol Morphol       Date:  2014-06-27       Impact factor: 2.309

7.  Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.

Authors:  Mio Kobayashi; Yuko Kakuda; Kenichi Harada; Yasunori Sato; Motoko Sasaki; Hiroko Ikeda; Mitsuhiro Terada; Munenori Mukai; Shuichi Kaneko; Yasuni Nakanuma
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

8.  Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.

Authors:  Roger Klein Moreira; Frank Revetta; Elizabeth Koehler; Mary Kay Washington
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

Review 9.  Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).

Authors:  Jochen Mattner
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

Review 10.  The immunogenetics of primary biliary cirrhosis: A comprehensive review.

Authors:  G J Webb; K A Siminovitch; G M Hirschfield
Journal:  J Autoimmun       Date:  2015-08-03       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.